These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1000060)

  • 1. Aromatic hydroxylation of ellipticine in rats: lack of an NIH shift.
    Reinhold VN; Bruni RJ
    Biomed Mass Spectrom; 1976 Dec; 3(6):335-9. PubMed ID: 1000060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the metabolites of ellipticine in rat bile.
    Branfman AR; Bruni RJ; Reinhold VN; Silveira DM; Chadwick M; Yesair DW
    Drug Metab Dispos; 1978; 6(5):542-8. PubMed ID: 30603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative physiological disposition of ellipticine in several animal species after intravenous administration.
    Chadwick M; Silveira DM; Platz BB; Hayes D
    Drug Metab Dispos; 1978; 6(5):528-41. PubMed ID: 30602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial transformations of natural antitumor agents: use of solubilizing agents to improve yields of hydroxylated ellipticines.
    Chien MM; Rosazza JP
    Appl Environ Microbiol; 1980 Oct; 40(4):741-5. PubMed ID: 7425624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of deuterium-labelled elliptinium and its use in metabolic studies.
    Gouyette A
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):243-7. PubMed ID: 3365494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH shift in the hydroxylation of aromatic compounds by the ammonia-oxidizing bacterium Nitrosomonas europaea. Evidence against an arene oxide intermediate.
    Vannelli T; Hooper AB
    Biochemistry; 1995 Sep; 34(37):11743-9. PubMed ID: 7547906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.
    Maftouh M; Meunier G; Dugue B; Monsarrat B; Meunier B; Paoletti C
    Xenobiotica; 1983 May; 13(5):303-10. PubMed ID: 6636827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
    Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
    Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats.
    Lesca P; Lecointe P; Paoletti C
    Biochem Pharmacol; 1977 Nov; 26(22):2169-73. PubMed ID: 588300
    [No Abstract]   [Full Text] [Related]  

  • 10. Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxyellipticines.
    Chien MM; Rosazza JP
    Drug Metab Dispos; 1979; 7(4):211-4. PubMed ID: 39722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of beta-adrenergic antagonists. Evidence for an arene oxide-NIH shift pathway in the aromatic hydroxylation of oxprenolol.
    Nelson WL; Burke TR
    J Med Chem; 1979 Sep; 22(9):1088-92. PubMed ID: 490554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic transformation of 2-methylellipticinium.
    Malvy C; Paoletti C
    Biochem Biophys Res Commun; 1980 Sep; 96(1):363-9. PubMed ID: 7437041
    [No Abstract]   [Full Text] [Related]  

  • 13. Acebutolol and alprenolol metabolism predictions: comparative study of electrochemical and cytochrome P450-catalyzed reactions using liquid chromatography coupled to high-resolution mass spectrometry.
    Bussy U; Delaforge M; El-Bekkali C; Ferchaud-Roucher V; Krempf M; Tea I; Galland N; Jacquemin D; Boujtita M
    Anal Bioanal Chem; 2013 Jul; 405(18):6077-85. PubMed ID: 23700103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Phase II metabolites of rutaecarpine in rat by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Lee SK; Lee DW; Jeon TW; Jin CH; Kim GH; Jun IH; Lee DJ; Kim SI; Kim DH; Jahng Y; Jeong TC
    Xenobiotica; 2005 Dec; 35(12):1135-45. PubMed ID: 16418066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.
    Maftouh M; Monsarrat B; Rao RC; Meunier B; Paoletti C
    Drug Metab Dispos; 1984; 12(1):111-9. PubMed ID: 6141901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
    Stiborová M; Borek-Dohalská L; Aimová D; Kotrbová V; Kukacková K; Janouchová K; Rupertová M; Ryslavá H; Hudecek J; Frei E
    Gen Physiol Biophys; 2006 Sep; 25(3):245-61. PubMed ID: 17197724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of electrochemical detection in the high-performance liquid chromatographic determination of hydroxylated ellipticine derivatives.
    Bellon P; Canal P; Bernadou J; Soula G
    J Chromatogr; 1984 Jul; 309(1):170-6. PubMed ID: 6480764
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
    Auclair C; Paoletti C
    J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of urinary and biliary metabolites of alprenolol in the rat.
    Hoffmann KJ; Arfwidsson A; Borg KO; Skånberg I
    Xenobiotica; 1979 Feb; 9(2):93-106. PubMed ID: 433314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of phenytoin to 5-(4-hydroxyphenyl)-5-phenylhydantoin in the rat and in man.
    Claesen M; Moustafa MA; Adline J; Vandervorst D; Poupaert JH
    Drug Metab Dispos; 1982; 10(6):667-71. PubMed ID: 6130920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.